Skip to main content

Table 4 Independent predictors of 1-year events by multivariate Cox analysis

From: Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China

  HFmrEF vs HFrEF HFmrEF vs HFpEF
p value HR/OR (95% CI)   p value HR/OR (95% CI)  
All-cause mortalitya 0.022 0.437 (0.215–0.887) 0.488 1.320 (0.602–2.894)
Cardiovascular mortalityb 0.005 0.270 (0.108–0.672) 0.455 1.554 (0.488–4.950)
MACEc 0.034 0.450 (0.215–0.941) 0.093 2.138 (0.882–5.183)
Hospitalization due to HFd 0.952 1.017 (0.588–1.758) 0.199 0.721 (0.438–1.187)
  1. Abbreviations: HFrEF heart failure with reduced ejection fraction, HFmrEF heart failure with mid-range ejection fraction, HFpEF heart failure with preserved ejection fraction, MACE major adverse cardiac events
  2. aFinal multivariate model adjusted for sex, non-solitary, Montreal cognitive assessment, tobacco use, angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers
  3. bFinal multivariate model adjusted for sex, non-solitary, abnormal jugular venous pressure, diabetes mellitus, tobacco use
  4. cFinal multivariate model adjusted for sex, non-solitary, New York Heart Function Assessment, diabetes mellitus, chronic kidney disease, stroke, tobacco use
  5. dFinal multivariate model adjusted for New York Heart Function Assessment, abnormal jugular venous pressure, pulse, systolic blood pressure, chronic kidney disease, stroke, family history of HF, cardiac hospitalization
  6. Statistically significant variables were highlighted in bold